Hope and self-efficacy are associated with better satisfaction with life in people with ALS

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Shir GalinMarc Gotkine

Abstract

The psychological phenotype in amyotrophic lateral sclerosis (ALS) is less negative than in other neurodegenerative diseases, manifested by a lower prevalence of psychopathology, such as anxiety and major depression, and a higher perceived quality of life by patients, irrespective of physical impairment. We hypothesized that positive psychological factors such as hope, optimism, and self-efficacy in people with ALS (PALS) were key determinants of satisfaction with life (SWL), despite physical impairment, and were protective against psychopathology. Forty PALS, at different functional levels, completed objective questionnaires to evaluate psychological factors of hope, optimism, self-efficacy, and SWL. Approximately 41% of the variance in SWL was accounted for by the Agency factor of hope. The results indicated that SWL was significantly correlated to specific positive psychological factors of hope and self-efficacy. Physical impairment was not correlated with positive psychological factors or SWL. These results support the role of hope and self-efficacy in maintaining satisfaction with life in PALS and consideration of these potentially modifiable factors could improve palliative therapy.

References

Oct 1, 1991·Journal of Personality and Social Psychology·T R ElliottJ T Hoffman
Apr 1, 1991·Journal of Personality and Social Psychology·C R SnyderP Harney
Jun 1, 1990·The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses·A W FooteP Daffin
Oct 1, 1989·Journal of the Neurological Sciences·H Hayashi, S Kato
Jan 1, 1994·Archives of Neurology·E R McDonaldR A Walter
Aug 1, 1993·Journal of Personality and Social Psychology·C S CarverK C Clark
Aug 1, 1997·Social Science & Medicine·A M Barnwell, D J Kavanagh
Feb 24, 1998·Research in Nursing & Health·K B KingJ J Zerwic
Apr 8, 1998·Journal of Personality·L M IrvingJ J Crowson
Jul 1, 1997·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Z M ShnekJ Irvine
Mar 18, 1999·Social Science & Medicine·C L NekolaichukT O Maguire
May 5, 1999·Neurology·L GanziniW F Hoffman
Jul 7, 1999·Journal of Clinical Psychology·P R Magaletta, J M Oliver
Jan 25, 2002·Multiple Sclerosis : Clinical and Laboratory Research·S G LynchD R Denney
Aug 20, 2003·Journal of Consulting and Clinical Psychology·Joseph J Trunzo, Bernardine M Pinto
Aug 12, 2005·Neurorehabilitation and Neural Repair·Andrea KüblerNiels Birbaumer
Sep 16, 2005·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Charles S CarverRobert P Derhagopian
Feb 1, 1985·Journal of Personality Assessment·E DienerS Griffin
Dec 22, 2005·Acta Neurologica Scandinavica·A Lieberman
May 16, 2006·International Journal of Nursing Studies·Philip MoonsSabina De Geest
Apr 21, 2007·Journal of the Neurological Sciences·Janet E McLeod, David M Clarke
May 1, 2007·Multiple Sclerosis : Clinical and Laboratory Research·D A TrojanD Da Costa
Mar 28, 2008·Journal of Palliative Medicine·Joanna H FanosRobert G Miller
Dec 17, 2008·Psychology, Health & Medicine·Marita P McCabeElizabeth McDonald
Aug 28, 2009·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Heather N RasmussenJoel B Greenhouse
Jan 22, 2010·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Lisa G Aspinwall, Richard G Tedeschi
Apr 29, 2010·Current Psychiatry Reports·Lorenzo NorrisElham Bayat
Jul 1, 2010·Journal of Neurology, Neurosurgery, and Psychiatry·Tamara MatuzAndrea Kübler
Sep 29, 2011·The Journal of Urology·Jennifer E HeckmanMark S Litwin
Nov 8, 2011·Multiple Sclerosis : Clinical and Laboratory Research·Anthony Feinstein
Jan 18, 2014·International Journal of Behavioral Medicine·Sindia Madan, Kenneth I Pakenham
Mar 19, 2014·Trends in Cognitive Sciences·Charles S Carver, Michael F Scheier
Jan 1, 1992·The Australian Journal of Physiotherapy·K Henderson, J Cole

❮ Previous
Next ❯

Citations

Sep 29, 2020·Journal of Neuromuscular Diseases·Adrianna GuntonKerri Lynn Schellenberg
Aug 15, 2021·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Chiung-Yao YuYu-Ying Lu

❮ Previous
Next ❯

Related Concepts

Related Feeds

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Related Papers

Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række
Svein Bua
European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
A VignolaA Chiò
The Journal of the Association of Physicians of India
© 2022 Meta ULC. All rights reserved